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Abstract 
Systemic hypertension is an increasingly diagnosed disorder in dogs and cats and frequently occurs secondary 
to chronic kidney disease. Prevention of damage to organs such as the kidneys, brain, heart, and eyes is one of the 
primary concerns in the management of veterinary patients with hypertension. Hypertension can be classified as primary 
(essential) or secondary. Essential hypertension refers to hypertension for which the cause remains unknown after 
extensive diagnostic testing, whereas secondary hypertension is associated with underlying disease or administration of 
hypertensive agents. In contrast to humans, essential or idiopathic hypertension is rare in veterinary patients. In cats 
and dogs, systemic hypertension is most often associated with another disease or condition such as: Renal disease, 
hyperadrenocorticism, Hyperthyroidism, Pheochromocytoma, Primary hyperaldosteronism, Diabetes mellitus, Renal 
disease, especially chronic kidney disease (CKD), is the most common cause of hypertension in dogs; approximately 
31% to 93% of dogs may be hypertensive. The Main objective of this study is to determine the importance of the detection 
of arterial hypertension in elderly dogs and its impact on the pathogenesis of associated diseases. Other objectives are, 
to determine the prevalence of hypertension in elderly dogs, the significance of the clinical manifestations of systemic 
hypertension and the prevalence of the most common diseases affecting geriatric dogs. 
Keywords: Arterial hypertension, Hyperadrenocorticism, Chronic kidney disease, Secondary hypertension. 
 
Introduction 
The persistent elevation of systemic blood pressure is referred to “Systemic hypertension” 
(HT). Multiple end-organ systems are damaged due to chronic elevation of systemic blood 
pressure; some of this damage may be clinically obvious but some may be insidious. Blood pressure 
is discussed in terms of systolic and diastolic values. In people, when the systolic and diastolic 
values are elevated it is called combined HT, HT can be isolated systolic and isolated diastolic each 
of the three has differing morbidity and mortality rates. The importance and prevalence of isolated 
systolic or diastolic HT is understudied in dogs and cats, but it is clear that HT occurs in these 
species and is a cause of significant morbidity in some animals. Typically Systemic hypertension 
is classified as primary “essential” HT or secondary HT. There have been some attempts by some 
veterinary clinicians to distinguish essential HT from idiopathic HT which is systemic HT in the 
absence of overt, clinically apparent causal disease. The use of the term “idiopathic” acknowledges 
that there may be a causal disease like renal disease that is responsible for the HT but is still in a 
pre-clinical phase. The discovery of the cause of the HT is dependent on the thoroughness of the 
diagnostic testing especially when the underlying disease is rare like a pheochromocytoma. The 
majority of hypertensive dogs have developed HT as a complication of another systemic disease 
however some sporadic cases of essential HT in dogs have been published. The prevalence of HT 
varies with the population studied(Rebecca L. Stepien 2002). 
There is a low prevalence HT in the general canine population but it is much higher in 
certain populations. Studies have shown that chronic renal disease (especially glomerular disease), 
hyperadrenocorticism (HAC) and diabetes mellitus (DM) are the most common diseases associated 
with HT in dogs. 
The majority of studies report the prevalence of HT as 60–90% in dogs with chronic renal 
failure, and as 70–80% for dogs with HAC, Systemic HT is documented less frequently in dogs 
with DM with a prevalence of 25–45%. Less common conditions associated with HT in dogs 
include pheochromocytoma, acromegaly, primary hyperaldosteronism and use of hypertensive 





with increasing age in dogs, other studies found age and blood pressure were not significantly 
correlated. Male dogs tend to have slightly higher blood pressure readings than females but the 
difference is unlikely to be clinically significant. Healthy sight hounds like greyhounds, 
deerhounds have a higher normal range of blood pressures; normal resting blood pressure values 
may be up to 15 mmHg higher than other breeds of similar size. Development of HT in dogs is 
almost always associated with the concurrent presence of one or more identifiable underlying 
diseases. The search for an underlying condition responsible for the development of HT is an 
essential component of the diagnosis of HT in dogs (Rapoport GS 2001, Ortega TM 1996,Bodey 
AR 1996). 
The main objective of this study is to determine the importance of the detection of arterial 
hypertension in elderly dogs and its impact on the pathogenesis of associated diseases. 
Some other objectives are to determine the prevalence of hypertension in elderly dogs, the 
significance of the clinical manifestations of systemic hypertension and the prevalence of the most 
common diseases affecting geriatric dogs. 
 
Physiopathology 
As blood flows through the arteries it pushes against the inside of the arterial walls. The 
more pressure exerted on these walls, the higher the blood pressure will be. The blood pressure is 
also affected by the size of small arteries. The pressure of the blood flowing through relaxed 
muscular walls of arteries is lower than when the artery walls narrow, or constrict. 
When the heart beats to push blood out into the arteries, blood pressure is at its highest. 
However it is at its lowest when the heart relaxes to fill with blood again. When the heart muscles 
contract it is called systolic pressure. When it is at rest is called diastolic pressure. The systolic 
pressure is stated first and the diastolic pressure second. Blood pressure is measured in millimeters 
of mercury. 
The ABP (arterial blood pressure) is the product of cardiac output and total peripheral 
resistance. Cardiac output may be further factors as the product of the heart rate and stroke volume: 
ABP= (heart rate × stroke volume) × total peripheral resistance 
Thus any factor or process that persistently elevates any of these three determinants of 
ABP can cause systemic hypertension (William O Reece et al. 2015). 
Cardiac output and peripheral resistance 
The balance between the cardiac output and peripheral vascular resistance is necessary to 
maintain a normal blood pressure. Most patients with essential hypertension have a normal cardiac 
output but a raised peripheral resistance. Peripheral resistance is determined by small arterioles, 
the walls of which contain smooth muscle cells, not by large arteries or the capillaries. 
The rise in intracellular calcium concentration is thought to be related to the contraction of 
smooth muscle cells, which may explain the vasodilator effect of drugs that block the calcium 
channels. Prolonged smooth muscle constriction is thought to induce structural changes with 
thickening of the arteriolar vessel walls possibly mediated by Angiotensin, leading to an 
irreversible rise in peripheral resistance. 
It has been postulated that the peripheral resistance is not raised in very early hypertension 
and the elevation of the blood pressure is caused by a raised cardiac output, which is related to 
sympathetic overactivity. The subsequent rise in peripheral arteriolar resistance might therefore 
develop in a compensatory manner to prevent the raised pressure being transmitted to the capillary 






Blood pressure is mostly affected by the rennin angiotensin system where rennin gets 
secreted byjuxtaglomerular apparatus of the kidneyby 3 different factors: glomerular 
underperfusion, decreased salt intake or as a response to the sympathetic nervous system. 
Angiotensinogen is converted to Angiotensin I which is rapidly converted by the 
angiotensin converting enzyme (ACE) to Angiotensin II in the lungs. Angiotensin II causes 
elevation of blood pressure through the vasoconstrictor effect that it performs and through the 
stimulation of the release of aldosterone from the adrenal glands that causes sodium and water 
retention, which in turn causes further elevation in blood pressure (William O Reece et al.2015). 
Autonomic nervous system 
Arteriolar constriction and arteriolar dilatation can be caused by the stimulation of the 
sympathetic nervous system. Therefore the autonomic nervous system has an important role in the 
maintenance of a normal blood pressure. In addition it is important in the regulation of blood 
pressure in response to stress and physical exercise. 
Hypertension is related to an interaction between the autonomic nervous system and the 
renin-angiotensin system, together with other factors, including sodium, circulating volume 
(Guyton AC et al.2006). 
 
Types of hypertension 
Systemic hypertension, which is the sustained increases in BP (blood pressure), can 
generally be categorized into 1 of 3 types. It may be idiopathic hypertension not related to any 
disease, or it can be secondary hypertension which means in association with diseases that may 
increase blood pressure, or it can be stress-induced or white-coat hypertension. 
In the absence of any identifiable predisposing causes, hypertension is described by the 
terms primary or essential hypertension. Animals with hypertension frequently present subclinical 
kidney disease which makes it difficult to establish a valid diagnosis of primary or essential 
hypertension. A chronic increase in BP suggests that one or both of the neurohumoral and renal 
systems responsible for regulating BP is abnormal. In the absence of an overt clinically apparent 
disease that can cause secondary hypertension then the panel recommends the use of the term 
idiopathic in place of essential for animals. When reliable BP measurements demonstrate a 
sustained increase in BP concurrent with normal CBC, serum biochemistry, and urinalysis, then a 
diagnosis of idiopathic hypertension is established. Unfortunately, pressure dieresis, may be 
induced by elevated BP and thus, the presence of low urine specific gravity (<1.030) in a patient 
with high BP does not establish that kidney disease is present. However, the presence of 
concentrated urine (>1.030) makes kidney disease less likely. Since animals with idiopathic 
hypertension can have underlying subclinical kidney disease or other conditions that may cause 
secondary hypertension, in addition to the tests listed above, according to the clinical findings, 
additional tests may include renal ultrasound, measurement of glomerular filtration rate, and 
quantitative assessment of proteinuria, and blood cortisol profile. Depending on individual cases 
additional tests could include serum and urine aldosterone and catecholamine concentrations and 
adrenal ultrasound examination. Although secondary hypertension remains the most common 
category of high BP in dogs, idiopathic hypertension is more common than previously recognized 
(Boveeet al.1986, Tipettet al.1987, Maggio et al. 2000, Ellliottet al.2001). 
Secondary Hypertension 
When high BP is concurrent with clinical disease or a condition known to cause 
hypertension like hyperadrenocorticism, hyperaldosteronism, diabetes mellitus, CKD(chronic 
kidney disease), obesity, hypercholesterolemia, pheochromocytoma, hypothyroidism or associated 





glucocorticoids, mineralocorticoids, erythropoietin, sodium chloride, phenylpropanolamine, and 
nonsteroidal anti-inflammatory drugs, this type of hypertension is known as secondary 
hypertension. Despite effective treatment of the primary condition hypertension may persist and 
the BP may increase after therapy is initiated. Even if the condition causing the secondary 
hypertension is effectively resolved by therapeutic intervention, prompt serial follow-up 
evaluations should be done (Goy-Thollotet al.2002,Symeet al.2003). 
White-Coat Hypertension 
As a consequence of the measurement process, artifactual increase in BP occurs, generally 
due to autonomic nervous system alterations from the effects of excitement or anxiety on higher 
centers of the central nervous system. This artifact can be reduced or eliminated by altering 
measurement conditions to reduce the animal’s anxiety or measuring BP at the animal’s home. 
Presently there is no justification for treating white-coat hypertension in dogs or cats. Increases in 
BP induced by anxiety can lead to a false diagnosis of systemic hypertension. Some animals may 
exhibit a dramatic increase in BP whereas others do not, and some animals may even exhibit a 
decrease in BP as a result of the measurement process, therefore the effects of anxiety on BP are 
unpredictable.The latter effect presumably is due to parasympathetic nervous system over activity 
(Karteret al.2003, Remillard RL et al. 1991,Hamlin RL et al. 1982, belewet al. 1999). 
 
Measurement of blood pressure 
Invasive Blood Pressure Measurement 
This measurement involves arterial puncture (for acute measurement) or cannulation with 
use of a blood pressure monitor providing pressure tracings (figure 1). It provides a direct reflection 
of true intra-arterial pressure, but can be difficult for routine clinical use. The direct blood pressure 
monitoring is mainly used for anesthetic or acute critical care monitoring or in research 
situations(Stepien RL et al. 1999). 
 
Fig 1.Direct blood pressure measuring technique (Stein B, 2003) 
 
OscillometricBlood Pressure Measurement 
It is a common and useful technique that benefits from the use of an automatically inflating 
and deflating cuff that is wrapped around a limb or tail and relies on the detection of arterial 
pulsation (figure 2). These techniques have been shown to accurately track variations in blood 
pressure over time in conscious dogs. However individual measurements obtained 
oscillometrically may underestimate direct systolic blood pressure measurements by up to 5–20 





pressure results in conscious dogs (Stepien RL et al. 1999, Bodey AR et al.1996, Brown S et 
al.2001, Kallet AJ et al. 1997). 
 
Fig 2.Oscillometric blood pressure measurement (Amy Dixon-Jimenez et al. 2011) 
 
Doppler methods of Blood Pressure 
The Doppler method detects the arterial pulsation using piezoelectric crystals. The BP is 
measured using a hand inflated cuff (figure 3). This is a commonly-used and useful method of 
blood pressure measurement. Accuracy is dependent on user experience and meticulous attention 
to technique, and diastolic pressures can be difficult to discern in some animals (Sparks AH et 
al.1953, Stepien RL et al.1999). 
 
Fig 3.Doppler method general setup (Stein B, 2003) 
 
Photoplethysmographic blood pressure measurement 
This method estimates blood pressure based on attenuation of infrared radiation as a 
method of estimating arterial volume. Studies of its accuracy in conscious dogs and cats are not 
available (Brinns SH et al.1995). 
General Measurement Recommendations 
In most clinical situations the noninvasive blood pressure measurement is preferred. The 
American College of Veterinary Medicine Hypertension Consensus Panel 12 for acute blood 





The procedure should be performed the same way in every patient.Doppler methods are 
mostly used for dogs; the cuff size should be ~ 40% of circumference of limb or tail (figure 4)and 
always in alignment with the heart. 
Several measurements should be performed, a total from 3 to 5 with 30 seconds to 1 minute 
interval between reading. The mean of the reading is then used (Hypertension consensus panel 
2002). 
 
Fig 4.Demonstration of cuff placement over the cranial tibial artery in a dog 
(Rosemary A et al. 2016) 
 
Patient consideration 
Prior to any patient manipulation, the blood pressure should be measured to minimize the 
stress and have more accurate results. The owners presence to calm the animal can be 
beneficial.The patient should be placed in sternal or lateral recumbency, conscious and calm with 
no use of tranquilization to prevent interference with the results. It is recommended to keep the 
patient in the required position for a few minutes for batter adaptation to the procedure. 
 
Normal values for canine blood pressure 
The BP values for normal dogs have been reported in various studies (Table 1). These 
values vary according to several factors, including differences in subject populations, measurement 
techniques, and animal handling and other factors. Therefore the standardization of the technique 
in veterinary practice is important. In people, systolic BP and pulse pressure increases have been 
well-characterized. However in dogs the effects of age are less clear. Some studies have shown a 
small increase in BP of 1–3 mmHg/year in aging dogs. On the other hand, it has been reported that 
sex has an effect in dogs, with males having higher and intact females lower BP values, the 
difference being <10 mmHg. There are essential interbreed differences in the BP of dogs, most 
particularly with sighthounds (eg, Greyhounds and Deerhounds), in which BP is higher by 
approximately 10–20 mmHg than in mongrels. In other breeds the BP values vary by 7–10 mmHg 
but breed-specific ranges for normal and abnormal BP may need to be developed. Obesity is a 
factor for increases in BP in variety of species including dogs, an experimental study has shown a 
small (<5 mmHg) increase in BP was noted in obese dogs by oscillometry but not byDoppler 






Normal canine blood pressure values (Brown S et al.2007) 
 





28 144 ± 16 104 ± 13 81 ± 9 
Cowgillet 
al. 
21 148 ± 16 102 ± 9 87 ± 8 
Chalifouxet 
al. 
12 154 ± 31 115 ± 16 96 ± 12 
Stepienet al. 27 154 ± 20 107 ± 11 84 ± 9 
Oscillometry Bodey and 
Michell 
1267 131 ± 20 97 ± 16 74 ± 15 
Coulteret al. 51 144 ± 27 110 ± 21 91 ± 20 
Kalletet al. 14 137 ± 15 102 ± 12 82 ± 14 
Stepienet al. 28 150 ± 20 108 ± 15 71 ± 18 





12 145 ± 23  
Stepienet al. 28 151 ± 27 
Remillardet 
al. 
5 150 ± 16 
 
Interpretation of results 
The risk factor is distributed according to the systolic blood pressure and end-organ 
damage. If the SBP (systolic blood pressure) < 150/95, there is minimal risk, so no further 
diagnostics indicated.If the SBP 150/95 → 160/100, there is low risk, High blood pressure should 
be confirmed by several measurements. If there are no clinical signs or causative disease then 
search for underlying disease is recommended. Monitor over intervals of time if no disease found. 
If the SBP 160/100 → 180/120, there is moderate risk.Attentive search for underlying 
disease should be performed. Therapy should be initiated if clinical signs are present or when rapid 
resolution of underlying disease is not anticipated. Monitor over time if no disease found. 
If the SBP > 180/120, there is high risk.If ocular or neurologic signs are present;treat first, 
then proceed with diagnostic work-up for underlying disease If high risk associated disease is 
present; therapy is indicated.If no clinical signs and no associated diseases are present then recheck 
frequently: if consistently abnormal, consider therapeutic trial of antihypertensive medication 
(Cowgill LG et al.1983, Stepien RL et al. 1999, Kallet AJ et al. 1997, Remillard RL et al. 1991, 
Sparks AH et al.1999). 
 
Causes of hypertension 
The most commonly associated diseases with hypertension are chronic glomerular disease 
or tubulointerstitial diseases associated with proteinuria. When the systemic blood pressure is 
elevated, the kidneys initial response is to increase renal excretion of water and sodium, this 
mechanism acts to reduce the circulating blood volume and therefore decrease systemic 
hypertension. However persistent elevation in blood pressure leads to renal tubular degeneration 





glomerular atrophy, and proliferative glomerulitis. Eventually this will lead to worsening of the 
hypertension and eventual renal failure(Cainet AE, Khalil RA 2002). 
Several clinical signs may appear during CKD including vomiting, lethargy, diarrhea, 
constipation, depression, weight loss, polydipsia, anorexia, acute blindness, seizures and coma, 
hematuria, polyuria. 
Hyperadrenocorticism 
Canine hyperadrenocorticism (HAC) is a common condition seen most frequently in 
middle aged to older dogs. The pathophysiology of hypertension associated with 
hyperadrenocorticism potentially include excessive secretion of renin and activation of the renin– 
angiotensin system, enhanced vascular sensitivity to catecholamines (vasoconstriction) and a 
reduction of vasodilator prostaglandins. 
It has also been postulated that hypertension in Cushing's syndrome is due to decreased 
renal conversion of cortisol to cortisone by the enzyme 11bHSD2, which would increase 
mineralocorticoid action. The high cortisol levels in Cushing's syndrome overwhelm the 11bHSD2 
enzyme because of substrate saturation of mineralocorticoid receptors by cortisol. This mechanism 
will result in an excessive mineralocorticoid function. This excessive state will lead to 
hypokalemia, increased renal tubular sodium reabsorption, intravascular volume expansion, and 
hypertension. However, recent studies have shown that this phenomenon is not the only mechanism 
involved in hypertension and that glucocorticoids receptors are involved in the development of 
hypertension in Cushing's syndrome. 
The clinical signs and physical examination findings characteristic for this syndrom 
include polyuria, polydipsia, polyphagia, abdominal distension, hepatomegaly and dermatologic 
changes such as bilaterally symmetrical alopeciaandpyoderma, urinary tract infections, diabetes 
mellitus, proteinuric renal disease, and pulmonary thromboembolism (Meliánet al. 
2010,Herrtageet al. 2012, Goy-thollotet al., Fraser et al.1989, Connell et al.1988). 
Diabetes mellitus 
Diabetes mellitus is a chronic disorder of carbohydrate metabolism due to relative or 
absolute insulin deficiency. Clinical signs of diabetes include polydipsia, polyuria, polyphagia with 
weight loss, bilateral cataracts, and weakness. 
The pathophysiology between the occurrence of diabetes mellitus and hypertension 
remains unclear however some studies show that it is related to the formation of atherosclerosis. 
The development of diabetes-related atherosclerosis includes the following steps: 
endothelial injury, smooth muscle cell proliferation, foam cell development and infiltration, 
platelet activation, and increased inflammation. External sources of injury to the endothelial cells 
and hemodynamic changes create lesions. When the endothelial permeability increases, the 
retention of deleterious low-density lipoproteins (LDL) will occur, these LDL will interact with 
the underlying extracellular matrix (ECM). This interaction will lead to the adherence of LDL to 
the vessel wall where it is oxidized by reactive oxygen species (ROS), which are increased during 
diabetes. Once oxidized, theses LDL stimulate the overlying endothelial cells to upregulate cellular 
adhesion molecules, chemotactic proteins, growth factors, and inhibit nitric oxide (NO) production. 
These factors will lead to the recruitment of monocytes and macrophages, which interact with 
highly oxidized aggregated LDL to form foam cells. The activated macrophages will produce Pro- 
inflammatory cytokines and stimulate the proliferation of vascular smooth muscle cells.ECM is 
produced by the Intimal smooth muscle cells which gives rise to a fibrous cap. The resulting 
complex plaque is unstable and prone to rupture and may lead to an acute vascular occlusion (figure 







Fig 5.Atherosclerosis formation mechanism (Faxon DP et al. 2004) 
 
Pheochromocytoma 
It is a tumor of the adrenal medulla where catecholamines are excessively secreted 
resulting in hypertension due to several mechanisms: vasoconstriction, positive inotropic and 
chronotropic effect. The Clinical signs associated with this condition are often vague and 
intermittent, and may be similar more common diseases such as hyperadrenocortisism, diabetes 
mellitus, hepatic or renal disease, or other neoplasms. Clinical signs frequently observed include 
weakness, collapse, lethargy, anorexia, vomiting, panting, weight loss, anxiety, restlessness, 
polyuria, polydipsia, diarrhea, abdominal distention, epistaxis, seizures or acute blindness. The 
clinical signs are due to excessive secretion of catecholamine and systemic hypertension. The 
sudden release of catecholamines will lead to the rise of blood pressure wchich leads to precipitate 
acute congestive heart failure, pulmonary edema, myocardial infarction, ventricular fibrillation and 
cerebral hemorrhage(Manger et al.1996, Jones et al. 1997, Jubbet al. 1993, Locke-bohannon 2001). 
Hyperaldosteronism 
It is an excessive secretion of aldosterone by the adrenal glands. Mineralocorticoids cause 
an increase in blood pressure by increasing the reabsorption of sodium and therefore expanding 
extracellular fluid (ECF) leading to greater intravascular volume and increased arteriolar 
resistance. 
Clinical signs include lethargy, weakness, anorexia, cervical ventroflexion, paresis, ataxia, 
collapse and polyuria, polydipsia along with signs indicating the presence of hypertension 
including hyphema, retinal detachment, hypertensive retinopathy and blindness (Weber KT 2001). 
However the resolution of endocrinopathy might not restore normal BP in dogs.Metabolic 
abnormalities such as obesity or hypercholesterolemia may result in hypertension. 
 
Consequences and clinical signs of hypertension 
Clinical signs do not appear directly with persistently elevated systemic blood pressure but 
this persistent elevation can lead to substantial damage to a variety of tissues and body systems 
over time. Essentially, the eyes, kidneys, central nervous system, and cardiovascular system are 
affected by persistent high ABP and they are commonly referred as the target organs of systemic 
hypertension. 
Ocular system 
The most common presenting complaint for animals with systemic hypertension is the 
sudden onset of blindness from hypertensive retinopathy, possibly because routine screening of 
animals for hypertension by ABP measurement is uncommon. As with microvascular beds, the 





walls, with resultant abnormalities including hemorrhage within retina(figure 6), vitreous, or 
anterior chamber, retinal detachement and atrophy, retinal edema perivasculitis, retinal vessel 
tortuosity and glaucoma (Smith et al.2016). 
 
Fig 6.A dog with intraocular hemorrhage or hyphema causing sudden blindness 
(Bonagura, 2015) 
 
Central nervous system 
Head tilting, depression, seizures, which are signs consistent with cerebrovascular 
hemorrhage have been seen clinically in dogs with uncontrolled hypertension, and are often 
associated with a poor prognosis. 
The brain has an autoregulation system for its circulation which generally works well. The 
rise in ABP causes the constriction of small arteries and arterioles which is responsible for this 
autoregulatory control. This phenomenon will protect the central nervous system from many of the 
adverse effects of systemic hypertension across a broad range of ABPs. However, these arterioles 
have a limited ability to prevent the transmission of elevated ABPs to the local microcirculation 
(arterioles, capillaries, and venules). When the ABP rises above the autoregulation limit, the 
pressure and the flow within the microcirculation increases, which causes an alteration in Starling 
forces across the capillary wall. Following the rise in intracapillary hydrostatic pressure, in 
particular, the transcapillary fluid filtration tends to increase, promoting the development of 
interstitial edema within the brain parenchyma. If the pressure rises far enough, especially if the 
rise is acute, local edema formation occurs and this can lead to cerebral herniation which is 
generally a fatal complication. The rise in intracranial pressure due to the increase in interstitial 
volume causes neurological dysfunction also referred to as hypertensive encephalopathy, 
especially because the brain is compartmentalized within the bony cranium compartment. Clinical 
signs caused by brain edema may include disorientation, ataxia, stupor, com and seizures. 
A rapid severe rise in ABP is highly causative of hypertensive encephalopathy. The 
rapidity of rise of ABP affects the likelihood of development of edema, unlike with chronic 
hypertension (weeks to months in duration) where the arterioles are allowed to adapt, leading to an 
increase in the upper limit of tolerable ABP. 
Medium and small arteries can be damaged and ruptured due to hypertension which results 
in localized ischemia (stroke) and tissue death (infarct). The animal may therefore exhibit clinical 
signs such as ataxia, disorientation, seizure, stupor, or coma (Smith et al. 2016). 
Kidneys 
In humans, hypertension serves as the leading cause of renal disease and frequently the 
latter contributes to the genesis and maintenance of systemic hypertension. In dogs it has recently 





As in other vascular beds, high pressure in renal arterioles leads to thickening of small 
artery and arteriolar walls by the processes of hyaline arteriosclerosis and smooth muscle 
hypertrophy. This process can be unevenly distributed within the renal parenchyma, resulting in 
interspersed areas of ischemia and hyperperfusion. Areas of ischemia may result in overproduction 
of rennin with resultant increases in circulating levels of angiotensin II, further raising total 
peripheral resistance and stroke volume, and therefore worsening systemic hypertension (Francis 
W K Smith et al. 2016). 
 
Fig 7. Blood flow through the kidney (MonisRasool, Edupil.com) 
 
As a result to hyperperfusion in certain areas, an alteration in Starling forces in the 
glomerular capillary bed, with an elevation in glomerular capillary hydrostatic pressure will be 
initiated. When the glomerular capillary bed is injured, glomerulosclerosis(figure 7 and 8) will 
develop which is the production of obliterative extracellular matrix production by glomerular 
mesangial cells.Persistent chronic rise in hypertension can lead to nephron destruction and 
contribute to progression of CKD. 
 
Fig 8.Formation of glomerulosclerosis (Blann, 2014) 
 
Chronic rise in systolic BP to values > 160mmHg leads to progressive renal injury in dogs 
and the severity of renal injury has been correlated to the degree of elevation. Systemic 





can result in ischemia, necrosis, atrophy and exacerbation of proteinuria. In living animals with 
preexisting kidney disease, the gradual and additive changes may be difficult to quantify. However 
if the systolic hypertension at the time of presentation is >160mmHg, the odds of uremic crisis and 
the death in dogs with CKD will increase. 
When there is high injury to the kidney due to hypertension, proteinuria is perhaps the best 
marker to demonstrate that. The presence of microalbuminuria or an elevated urine protein-to- 
creatinine ratio (> 0.5 in dogs) in a hypertensive animal (systolic BP > 160mmHg) should be 
considered an indication of ongoing renal damage (Francis W K Smith et al. 2016). 
Cardiovascular system 
Because of the increased arterial pressure (i.e., afterload), the heart will be subject to 
diastolic dysfunction, left ventricular hypertrophy (figure 9) and secondary valvular insufficiency. 
Left ventricular hypertrophy is the most commonly observed effect of hypertension in the 
cardiovascular system. The hypertrophy is concentric which means increased wall thickness 
without luminal dilation. Left ventricular hypertrophy can cause a loss of ventricular compliance, 
which will result in ventricular stiffness and reduced diastolic filling that will lead to the elevation 
in left ventricular diastolic pressure leading to pulmonary congestion, although this effect is minor 
in most hypertensive dogs (Smith et al. 2016). 
 
Fig 9.Different types of ventricular hypertrophy (Jop H.et al. 2013) 
 
Chronic high pressure induces vascular smooth muscle hypertrophy, in small arteries and 
arterioles the high BP leads to extravasation of plasma into the vessel wall, producing a thickening 







Fig 10.High blood pressure and atherosclerosis (Duggan 2008) 
 
When these two processes occur in systemic arterioles there will be a reduction in luminal 
diameter producing local ischemia or generalized increase in total peripheral vascular resistance. 
This will in turn exacerbate the systemic hypertension, an example of deleterious positive feedback 
loop and may contribute to vascular rupture (stroke) in the central nervous system. 
Table 2 
Evidence of target organ damage (Brown S et al. 2007) 
Tissue Hypertensiveinjury 
(TOD) 
Clinical findings indicative of TOD Diagnostic test (s) 
Kidney Progression 
kidney disease 
of chronic Serial increases in serum creatinine 
or decrease in glomerular filtration 
rate 
Serum creatinine and urea 
Urinalysis with quantitative 
assessement of proteinuria 
and albuminuria 
GFR measurement 
















Left ventricular hypertrophy 
Cardiac failure 












Diagnosis of Hypertension and associated diseases 
In the diagnosis of hypertension it is essential to recognize conditions that may be factors 
to increased BP, to determine the extent of TOD(target organ damage) (table 2), and to search if 
there are any seemingly unrelated concurrent conditions that may complicate antihypertensive 
therapy. The discovery of underlying diseases that may cause secondary hypertension should be 
identified and treated while continuing to monitor BP. 
A diagnosis cannot be made on the basis of a single measurement session, but on the basis 
of several measurements, as well as a thorough search for TOD (and conditions that may cause 
secondary hypertension) (figure 11 and 12). However when there is evidence of TOD consistent 
with hypertension such as hypertensive retinopathy/choroidopathy or encephalopathy, a single 
measurement of BP can be used to establish temporarily a rationale for antihypertensive therapy. 
Marked systemic hypertension and TOD have a solid association in dogs and cats, particularly for 
ocular and renal injury. But there are other adverse effects of systemic hypertension that are 
theorized on the basis of extrapolation from clinical studies in humans or from experimental studies 
in laboratory rodents (Bodey AR et al. 1996, Cox RH et al.1976). 
 
Fig 11.The recommended approach to patient evaluation (Brown S et al. 2007) 
 
The biochemistry panel is a series of tests performed on serum, in this study the tests 
included BUN (Blood Urea Nitrogen), creatinine, cholesterol, glucose, SGPT (serum glutamic 
pyruvic transaminase), ALP (Alkaline phosphatase). 
These tests provide information about the activity of the organs in the body and help detect 
any abnormalities. 
The purpose of each test performed is detailed below. 
Urea level increases in case of high dietary proteins, poor quality dietary protein, 
carbohydrate deficiency, catabolic states, dehydration, congestive heart failure, renal failure, 
blocked urethra, and ruptured bladder. It decreases in case of low dietary protein, gross sepsis, 
anabolic hormonal effects, liver failure, portosystemic shunts (congenital or acquired). This test is 






Creatinine level increases in case of renal malfunction, blocked urethra, and ruptured 
bladder. It decreases in case of sample deterioration. This test is used especially for the detection 
of renal disease which the reason this test was performed in this study (Whitebread, 2015). 
SGPT (serum glutamic-pyruvic transaminase) is a liver enzyme is present in the cytoplasm 
and mitochondria of hepatocytes and, therefore, increases in case of hepatocellular damage. It is 
interesting to perform this test in this study to detect liver damage that can cause hypertension like 
liver cirrhosis, however it is not specific (Whitebread, 2015). 
ALP (alkaline phophatase) level rises when there is an increased bone deposition, liver 
damage, cholestasis, intestinal damage, corticosteroid administration, barbiturate administration, 
generalized tissue damage (including neoplasia). The level also rises in hyperadrenocorticism and 
hyperthyroidism which are the main interest of this test in our study because they are common 
causes of hypertension in dogs (Whitebread, 2015). 
Glucose level increases after high-carbohydrate meals, sprint exercise, due to stress or 
excitement, glucocorticoid administration, overinfusion with glucose/dextrose-containing IV 
fluids. Increases in glucose levels in the blood are evident in diabetes mellitus and 
hyperadrenocorticism which are the reason for performing this test in this study because they 
induce hypertension. Glycemia decreases in case of insulin overdose, insulinoma, acute febrile 
illness, and idiopathically(Whitebread, 2015). 
Cholesterol level rises after ingestion of fatty meals, due to hepatic or biliary disease, 
protein-losing nephropathy, diabetes mellitus, hyperadrenocorticism, and hypothyroidism, the last 
three diseases stated are the reason for performing this test in this study because they are common 
conditions for the occurrence of hypertension. Cholesterolemia decreases in some cases of severe 
liver dysfunction and occasionally in hyperthyroidism (Whitebread, 2015). 
A CBC (complete blood count) gives information on the hydration status, anemia (CKD, 
atherosclerosis), infection, the blood's clotting ability, and the ability of the immune system to 
respond. For example in cushing disease leukocytosis and thrombocytosis can be present with the 
manifestation of the stress formula which is neutrophilia and lymphopenia(corticosteroids have 
direct cytotoxic action on lymphocytes), eaosinopenia(medullary sequestration of eosinophils) and 
monocytosis(Deborah S. Greco 2003). In diabetes a neutrophilia can be present but it is neither 
specific nor systematic. 
In pheochromocytoma, the CBC may reveal anemia (from chronic disease or blood loss) 
or a transient thrombocytopenia if the patient has platelet consumption from episodic 
hemorrhage. The leukogram often reveals leukocytosis characterized by a mature neutrophilia due 
to either catecholamine induced by demargination of neutrophils or necrosis/inflammation within 
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When systolic BP is sustained at >200mmHg or diastolic BP at >120mmHg, 
antihypertensive treatment should be indicated regardless of other clinical findings. 
 
Table 3 




The patient is considered a candidate for antihypertensive therapy when there is clear 
evidence of ongoing TOD. 
BP measurement in dogs presents considerable uncertainty and difficulty. Thus, according 
to table 3 when the BP is classified as AP2nc (no clinical abnormalities related to systemic 
hypertension are identified), the rationale for therapy is less clear(table 3). There is a difference of 
opinion between clinicians whether there is or not a need for treatment at this stage. Animals with 
no clinical signs and mildly elevated BP (AP1nc) should not be treated. 
Mostly in dogs the hypertension is secondary in dogs therefore antihypertensive drug 
therapy by itself is often not sufficient. It is important to identify and manage conditions likely to 
be causing secondary hypertension and to determine the extent of TOD (Kobayashi DL et al.1990, 
Ortega TM et al. 1996, Jacob F et al.2003). 
• * If blood pressure is not measured, the patientis classified as risk not determined. 
• Ɨ complications include any evidence of target organ damage in eyes (intraocular 
hemorrhage or retinal detachment), central nervous system (seizures or otherwise 
unexplained neurologic signs), cardovascular system (congestive heart failure), or 
kidneys (azotemia or proteinuria) 







Fig 13.Management of hypertension (Brown S et al. 2003) 
 
Conditions that cause secondary hypertension should be effectively managed to 
completely or partially resolve high BP. In order to start antihypertensive therapy, all clinically 
available information should be integrated and once the decision is made periodic re-evaluation is 
mandatory (figure 13). The therapy must be tailored to the patient and its associated conditions. 
The fewer the treatments the more preferable, once-daily treatment is ideal. Acute and abrupt 
decreases in BP should be avoided; a gradual, sustained reduction is the therapeutic goal.. In 
veterinary patients, the management of hypertension usually requires more than one agent, if the 
agent used is partially effective, an increase in the dosage or the addition of a new agent is 
considered. Dietary salt restriction is controversial in the management of high BP, there are 
evidence that suggest that sodium restriction alone does not decrease BP. On the contrary, in some 
cases sodium restriction activates the renin-angiotensin-aldosterone axis and may actually increase 
BP and therefore cause vascular, renal, and cardiac changes which will necessitate the utilization 
of antihypertensive agents that interfere with this hormonal system for example angiotensin- 
converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and aldosterone 
receptor blockers. On the other hand in animals with CKD, high salt intake may produce adverse 
consequences. Hypertension is managed in a stepwise manner by a staged institution of dietary and 
pharmacological regimens, taking into consideration all concurrent diseases and the extent of TOD. 
It is essential to evaluate the patient repeatedly, and adjust the treatment according to the evolution 
of the course of the diseases and the extent of TOD (Mathur S et al. 2002, Grauer G et al. 2000, 
Brown SA et al. 2003, Brown SA et al. 1993, Gaber L et al. 1994). 
Once a decision is made to treat an animal with hypertension, diet adjustment and 
therapeutic intervention with pharmacological agents is carried out. The selection of appropriate 
diet should be based on other patient-specific factors, such as underlying or concurrent diseases 





specific classes of agents, such as the use of beta-blockers for hypertension associated with 
hyperthyroidism. In the case of pheochromocytomas, alpha- and betablockers are used or surgical 
excision is performed. In animals suffering from hypertension associated to hyperaldosteronism, 
aldosterone receptor blockers or surgical excision of adrenal tumors are the best choices. As for 
dogs with CKD some combination of ACEI, ARB, and aldosterone receptor blockers are used. 
ACEI and calcium channel blockers (CCB) are the most widely used antihypertensive agents in 
veterinary medicine (King GL et al.2006, Brown SA et al. 2001, Brown SA et al. 2003, Brewster 
UC et al. 2003, Atkins CE et al. 2002). 
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